Results 151 to 160 of about 45,619 (223)

Half an hour of silence [PDF]

open access: yes, 2013
Van Gerrewey, Christophe
core  

Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma. [PDF]

open access: yesJ Clin Oncol
Wang M   +22 more
europepmc   +1 more source

5-Azacytidine treatment inhibits the development of lung cancer models via epigenetic reprogramming and activation of cellular pathways with anti-tumor activity. [PDF]

open access: yesMed Pharm Rep
Munteanu RA   +17 more
europepmc   +1 more source

MicroRNAs expression profile in chemotherapy-induced cardiotoxicity in NSCLC using a co-culture model. [PDF]

open access: yesBiomol Biomed
Romitan M   +10 more
europepmc   +1 more source

Presentación dossier sobre Mircea Eliade

open access: yesAyllu-Siaf, 2023
Rafael Garcia Pavon
doaj  

Randomized, open-label, phase 2 study of nivolumab plus ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden. [PDF]

open access: yesJ Immunother Cancer
Schenker M   +27 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy